August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Jose Fernando Moura: Phase 2 PERLA trial shows a new option in same setting NSCLC 1st line.
Oct 21, 2023, 19:37

Jose Fernando Moura: Phase 2 PERLA trial shows a new option in same setting NSCLC 1st line.

Jose Fernando Moura, Oncologist and Principal Investigator in Solid Tumors at Real Hospital Portuguese and IMIP, shared on X/Twitter from ESMO23:

“One more for the team! Phase 2 PERLA trial shows a new option in same setting NSCLC 1st line similar activity.”

Jose Fernando Moura: Phase 2 PERLA trial shows a new option in same setting NSCLC 1st line.

Source: Jose Fernando Moura/Twitter.